Trevena
TRVN
#10609
Rank
NZ$0.01 M
Marketcap
NZ$0.02077
Share price
0.00%
Change (1 day)
-99.26%
Change (1 year)

Trevena (TRVN) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$65.02 Million

According to Trevena's latest financial reports the company's total debt is NZ$65.02 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Trevena - Total debt on balance sheet (from 2012 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$57.31 M84.1%
2022-12-31NZ$31.13 M199.45%
2021-12-31NZ$10.39 M-3.88%
2020-12-31NZ$10.81 M-45.89%
2019-12-31NZ$19.98 M-22.96%
2018-12-31NZ$25.94 M-34.62%
2017-12-31NZ$39.68 M49.98%
2016-12-31NZ$26.45 M-0.47%
2015-12-31NZ$26.58 M1122.64%
2014-12-31NZ$2.17 M
2013-12-31N/A-100%
2012-12-31NZ$5.91 M938.98%
2011-12-31NZ$0.56 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
NZ$94.49 B 145,217.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$2.07 B 3,086.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$71.61 B 110,042.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ$5.83 M-91.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA